ResearchMoz

Global Human Vaccines Market 2011-2015

Technavio
Published Date » 2012-06-13
No. Of Pages » 42
   
 TechNavio's analysts forecast the Global Human Vaccines market to reach US$57.6 billion by 2015. One of the key factors contributing to this market growth is the increase in demand for vaccination against communicable diseases. The Global Human Vaccines market has also been witnessing the increase in awareness programs worldwide. However, emergence of vaccine-resistant viruses could pose a challenge to the growth of this market.  
   
 TechNavio's report, the Global Human Vaccines Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Human Vaccines market landscape and its growth prospects in the coming years. The report also...
Table of Content

1. Executive Summary

2. Introduction

3. Market Coverage

Market Overview
Key Products

4. Market Landscape
Market Size
Market Segmentation by Vaccine Application
Market Segmentation by Consumers
Market Size of Global Pediatric Vaccines Market
Five Forces Analysis

5. Geographical Segmentation

6. Key Leading Countries

USA
Germany
France
UK

7. Rate of Incidence and Prevalence

8. Vendor Landscape

9. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

Drivers and their Impact: End-users
Drivers and their Impact: Geography

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Key Vendor Analysis

15.1 GlaxoSmithKline plc
Business Overview
SWOT Analysis
15.2 Sanofi S.A.
Business Overview
SWOT Analysis 32
15.3 Pfizer Inc.
Business Overview
SWOT Analysis
15.4 Merck and Co. Inc.
Business Overview
SWOT Analysis

16. Other Reports in this Series

List of Tables


Exhibit 1: Global Human Vaccines Market 2011-2015 (US$ billion)
Exhibit 2: Global Human Vaccines Market Segmentation
Exhibit 3: Global Human Vaccines Market Segmentation by Application 2011
Exhibit 4: Global Human Vaccines Market Segmentation by Consumers 2011
Exhibit 5: Global Pediatric Vaccines Market 2011-2015 (US$ billion)
Exhibit 6: Global Human Vaccines Market by Geographical Segmentation 2011
Exhibit 7: Hepatitis C Infection by Source in 2011
Exhibit 8: Global Human Vaccines Market by Vendor Segmentation 2011

List of Figures

NA

Upcoming Reports:

Soy Dessert Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Soy is a nutritional food product, widely accepted by almost all cultures across the globe. Soy-milk has gained popularity among the lactose intolerant population. Due to the low amount of carbohydrates, fats and cholesterol in soy milk compared to dairy milk, it is a popular choice among the modern health conscious population. Soy-desserts are a product of soy milk, which has lately gained immense popularity due to the nutritional value of soy-milk. Soy-desserts mainly include soy-ice creams, soy-pudding, soy-cheesecake, and different soy-pies which are entirely dairy-free and made...
Pediatric Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Pediatric drugs are a special class of drugs which are prescribed to children and infants for different diseases.  These drugs are recommended in various conditions such as asthma, anorexia, birth defects, cancer in children, growth deficiencies, juvenile diabetes, attention deficit hyperactivity disorder, and others. Various acts have been passed to control pediatric drugs such as Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA). These acts have been introduced to increase the investments on R&D for pediatric drugs and to...
Flexible AC Transmission Equipment Market - Global Industry Analysis, Market Share, Drivers, Restraints, Growth And Forecast, 2013 - 2019
By - Transparency Market Research
Flexible AC Transmission (FACT) Equipment market has seen swift growth in recent years. The swift growth is attributed to growing desire to effectively address transmission loss, voltage fluctuation and several other problems associated with the electricity transmission. The technical advances in Flexible AC equipments; including network reliability, reduced failure rate, and low maintenance cost have made them superior to fixed compensation equipments. Thus, growing demand for reliable network and quality power transmission has offered impetus to the growth of Flexible AC transmission...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Blackstone Invests $800 Million in Asian Oil-Based Energy Company
Jul 31, 2014  
Blackstone Energy Partners announced to invest $800 million in an Asian based energy company that is led by former industry executives.  Blackstone is popularly considered a part of the world’s largest administrator of alternatives to financial stocks and bonds. New York-based managing director, Angelo Acconcia of Blackstone Energy Partners said in an interview that Tamarind...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...